Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
3.030
-0.090 (-2.88%)
At close: Jun 13, 2025, 4:00 PM
3.030
0.00 (0.00%)
After-hours: Jun 13, 2025, 4:00 PM EDT
Daré Bioscience Market Cap
Daré Bioscience has a market cap or net worth of $26.82 million as of June 13, 2025. Its market cap has decreased by -43.54% in one year.
Market Cap
26.82M
Enterprise Value
20.06M
1-Year Change
-43.54%
Ranking
Category
Stock Price
$3.03
Market Cap Chart
Since April 10, 2014, Daré Bioscience's market cap has decreased from $98.00M to $26.82M, a decrease of -72.64%. That is a compound annual growth rate of -10.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 13, 2025 | 26.80M | -1.11% |
| Dec 31, 2024 | 27.10M | -11.15% |
| Dec 29, 2023 | 30.50M | -56.68% |
| Dec 30, 2022 | 70.40M | -54.05% |
| Dec 31, 2021 | 153.20M | 200.98% |
| Dec 31, 2020 | 50.90M | 271.53% |
| Dec 31, 2019 | 13.70M | 69.14% |
| Dec 31, 2018 | 8.10M | -38.17% |
| Dec 29, 2017 | 13.10M | -32.47% |
| Dec 30, 2016 | 19.40M | -74.67% |
| Dec 31, 2015 | 76.60M | -38.82% |
| Dec 31, 2014 | 125.20M | 27.76% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 728.46B |
| Johnson & Johnson | 376.33B |
| Novo Nordisk | 353.21B |
| AbbVie | 338.88B |
| UnitedHealth Group | 287.65B |
| Abbott Laboratories | 237.12B |
| Novartis AG | 231.84B |
| AstraZeneca | 229.07B |